Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

If you see your cardiologist and they throw out the term “heart failure,” your heart might figuratively skip a beat. The ...

If you are one of those who pop painkillers all too often, then you might be raising your risk of heart attack and heart ...

Explore the latest advancements in heart disease medications, including statins, beta-blockers, ACE inhibitors, and more, for improved heart health.

The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with ...

The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

Trials and Tribulations of Cell Therapy for Heart Failure, an Update on Ongoing Trials Dec. 2, 2024 — A critical review of cell-based and cell product-based therapies for the treatment of heart ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...